Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.
Annual jab for HIV protection passes trial hurdle
Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.
Annual jab for HIV protection passes trial hurdle